1. Home
  2. HMY vs KYMR Comparison

HMY vs KYMR Comparison

Compare HMY & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Gold Mining Company Limited

HMY

Harmony Gold Mining Company Limited

N/A

Current Price

$19.20

Market Cap

10.3B

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$119.36

Market Cap

10.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HMY
KYMR
Founded
1950
2015
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
10.6B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
HMY
KYMR
Price
$19.20
$119.36
Analyst Decision
Buy
Strong Buy
Analyst Count
2
26
Target Price
$16.00
$107.72
AVG Volume (30 Days)
3.2M
649.1K
Earning Date
02-04-2016
04-30-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,211,000.00
Revenue This Year
$37.43
$10.61
Revenue Next Year
$27.44
$8.17
P/E Ratio
$15.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.03
$40.10
52 Week High
$26.04
$130.05

Technical Indicators

Market Signals
Indicator
HMY
KYMR
Relative Strength Index (RSI) 48.46 52.58
Support Level $19.19 $108.87
Resistance Level $19.69 $120.37
Average True Range (ATR) 0.68 4.70
MACD -0.33 -0.55
Stochastic Oscillator 5.57 42.92

Price Performance

Historical Comparison
HMY
KYMR

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: